3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
33
Thoracic
4
Plasma cell
3
Genitourinary
2
Gastrointestinal
2
CNS
2
Sarcoma
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Breast
1
Conditions
Lymphoma
549
Precursor Cell Lymphoblastic Leukemia-Lymphoma
511
Lymphoma, Non-Hodgkin
437
Lymphoma, Follicular
405
Lymphoma, Large B-Cell, Diffuse
392
Leukemia, Lymphocytic, Chronic, B-Cell
392
Lymphoma, B-Cell
248
Lymphoma, Mantle-Cell
224
Hodgkin Disease
209
Recurrence
205
Leukemia, Myeloid, Acute
199
Leukemia
196
Multiple Myeloma
185
Burkitt Lymphoma
185
Lymphoma, B-Cell, Marginal Zone
170
Neoplasms
153
Myelodysplastic Syndromes
134
Hematologic Neoplasms
115
Waldenstrom Macroglobulinemia
103
Lymphoma, T-Cell, Peripheral
86
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
83
Lymphoma, T-Cell
82
Lymphoma, T-Cell, Cutaneous
67
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
63
Mycosis Fungoides
57
Leukemia, Biphenotypic, Acute
55
Breast Neoplasms
55
Leukemia, B-Cell
52
Myeloproliferative Disorders
50
Lymphoproliferative Disorders
47
Interventions
enoxaparin sodium
1
apixaban
1
Rivaroxaban
1
Heparin, Low-Molecular-Weight
1
Enoxaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Venous Thromboembolism
×
Lymphoid
×
1 year
×
Clear all
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled